Patent details

Basic Information

Publication number:

EP1043976

PCT Application Number:

PCT/SE/1998/002368

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP989646310

PCT Publication Number:

WO/1999/032091

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ORAL PHARMACEUTICAL EXTENDED RELEASE DOSAGE FORM

French Title of Invention:

FORME POSOLOGIQUE PHARMACEUTIQUE ORALE A LIBERATION PROLONGEE

German Title of Invention:

ORALE PHARMAZEUTISCHE DOSIERUNGSFORM MIT VERLÄNGERTER WIRKSTOFFFREISETZUNG

SPC Number:

Dates

Filing date:

17/12/1998

Grant date:

14/12/2005

EP Publication Date:

14/12/2005

PCT Publication Date:

01/07/1999

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/10/2000

EP B1 Publication Date:

14/12/2005

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/12/2008

Expiration date:

17/12/2018

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/12/1998

 

 

Name:

AstraZeneca AB

Address:

-, 151 85 Södertälje, Sweden (SE)

Agent

Name:

VAN MALDEREN MICHEL

From:

28/12/2005

Address:

ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)

To:

Inventor

1

Name:

LUNDBERG Per, Johan

Address:

Sweden (SE)

2

Name:

KAREHILL Per-Gunnar

Address:

Sweden (SE)

Priority

Priority Number:

9704869

Priority Date:

22/12/1997

Priority Country:

Sweden (SE)

Classification

Main IPC Class:

A61K 9/20;

Filing date	Document type	Number of pages